Eli Lilly's Zepbound Achieves Remarkable 24% Weight Loss
Discover how Eli Lilly's weight-loss drug, Zepbound, delivers up to 24% weight loss, securing its competitive edge in the pharmaceutical market.
Topic
Weight Loss
A collection of 10 issues
Amgen's MariTide Achieves 20% Weight Loss Success
Amgen's new drug, MariTide, demonstrates significant promise with 20% weight loss and sustained results. Discover more about this breakthrough treatment.
Amgen's MariTide Achieves 20% Weight Loss
Discover how Amgen's MariTide achieves a significant 20% weight loss and maintains effectiveness in treatment. Explore this breakthrough in weight management.
Novo Nordisk's CagriSema Shows 23% Weight Loss in Trials
Novo Nordisk's CagriSema demonstrates 23% weight loss in clinical trials, slightly below expectations. Explore its potential impact on weight management solutions.
Weight-Loss Drug Market Faces Rising Competition and Supply Challenges
Explore the rising competition and supply hurdles in the weight-loss drug market. Discover key insights and future trends affecting this booming industry.
Novo Nordisk's CagriSema Achieves 22.7% Weight Loss
Novo Nordisk's experimental drug CagriSema shows promise with 22.7% weight loss in patients, approaching the anticipated 25%. Discover the latest in weight-loss research.
Retail Investors Rush to Novo Nordisk Amid Disappointing Drug Data
Retail investors are turning their attention to Novo Nordisk following underwhelming results from its weight-loss drug. Explore the healthcare investment trend.
Lilly Boosts Weight-Loss Market Position with Zepbound Approval
Eli Lilly strengthens its weight-loss market position with the approval of Zepbound, complementing its existing drug, Mounjaro. Discover more about Lilly's strategic expansion.
Zepbound Promises 18% Weight Loss in Clinical Trials
Discover how Zepbound helps patients achieve 18% body weight loss in clinical trials, offering hope for obesity management. Learn more about this breakthrough.
Zepbound Approved: Boosting Weight Loss and Sleep Apnea Solutions
Discover the impact of Zepbound's approval on pharmaceutical advancements in weight loss and sleep apnea treatments. Explore its significance in healthcare.